European Patent Office

T 0501/09 (Apoptosis/AMGEN INC.) of 25.06.2013

European Case Law Identifier
ECLI:EP:BA:2013:T050109.20130625
Date of decision
25 June 2013
Case number
T 0501/09
Petition for review of
-
Application number
96943576.7
Language of proceedings
English
Distribution
Distributed to board chairmen (C)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Apoptosis induced by monoclonal antibody anti-Her2
Applicant name
Amgen Inc.,
Opponent name
Fresenius Biotech GmbH
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 108European Patent Convention R 101(1)European Patent Convention R 99(2)Rules of procedure of the Boards of Appeal Art 12(4)
Keywords
Admissibility of appeal/patentee - statement of grounds (not filed)
Admissibility of appeal/opponent - appeal sufficiently substantiated (no)
Catchword
Admissibility of appeal, see points 2 to 8

ORDER

For these reasons it is decided that:

Both appeals are rejected as inadmissible.